US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.

During the first Trump TikTok ban effort, Oracle and Walmart were set to take a 20 percent stake in 'TikTok Global,' which included US operations as well as undisclosed other nations. Larry Ellison, Oracle founder, was a major supporter of Trump's 2016 bid.

Yes, that's the name of a 1994 Roland Emmerich movie. It's now a big infrastructure project to help power tech giants' foray into AI.

The new Stargate Project launched by several tech leaders, including OpenAI CEO Sam Altman and Oracle Chairman Larry Ellison, this week has fueled speculation that the $500B AI initiative can risk the relationship between the ChatGPT developer and its biggest investor,

What is Larry Ellison's net worth in 2025? What are the secrets behind the 80-year-old from New York City, who is currently considered the second-wealthiest man in the world behind

Microsoft won’t be the sole cloud provider for OpenAI but can decide whether to deliver the capacity or allow another company to do it.

Earlier, Trump had expressed openness to Tesla CEO Elon Musk or Oracle Chairman Larry Ellison acquiring the Chinese social media platform

Two of the most powerful tech leaders in the world, Microsoft CEO Satya Nadella and Tesla CEO Elon Musk, are not exactly fans of the $500 billion Stargate AI initiative announced by Trump this week.

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.

He previously floated a joint venture, saying that the US should be entitled to half of the app.

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early through a simple blood test, followed by gene sequencing of the tumour